# Comtech Telecommunications Corp: financial statements, quarterly

CMTL · Nasdaq · CIK 23197 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/cmtl.md) · [Financials](/companies/cmtl/financials.md) · [Filings](/companies/cmtl/filings.md) · [Insiders](/companies/cmtl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmtl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [152](/filings/0000023197-25-000009.md) | [134](/filings/0000023197-25-000039.md) | [128](/filings/0000023197-25-000056.md) | [126 d](/filings/0000023197-25-000080.md) | [116](/filings/0000023197-25-000100.md) | [127](/filings/0000023197-26-000037.md) | [127](/filings/0000023197-26-000069.md) | [(68.3) d](/filings/0000023197-26-000114.md) | [111](/filings/0000023197-25-000100.md) | [107](/filings/0000023197-26-000037.md) | [106](/filings/0000023197-26-000069.md) | [(74.2) d](/filings/0000023197-26-000114.md) |
| Cost of revenue | $m | [104](/filings/0000023197-25-000009.md) | [91.0](/filings/0000023197-25-000039.md) | [89.1](/filings/0000023197-25-000056.md) | [99.0 d](/filings/0000023197-25-000080.md) | [101](/filings/0000023197-25-000100.md) | [92.8](/filings/0000023197-26-000037.md) | [87.8](/filings/0000023197-26-000069.md) | [(76.3) d](/filings/0000023197-26-000114.md) | [74.3](/filings/0000023197-25-000100.md) | [70.5](/filings/0000023197-26-000037.md) | [69.9](/filings/0000023197-26-000069.md) | [(62.3) d](/filings/0000023197-26-000114.md) |
| Gross profit | $m | [47.9](/filings/0000023197-25-000009.md) | [43.2](/filings/0000023197-25-000039.md) | [39.0](/filings/0000023197-25-000056.md) | [27.1 d](/filings/0000023197-25-000080.md) | [14.5](/filings/0000023197-25-000100.md) | [33.7](/filings/0000023197-26-000037.md) | [38.9](/filings/0000023197-26-000069.md) | [8.0 d](/filings/0000023197-26-000114.md) | [36.8](/filings/0000023197-25-000100.md) | [36.2](/filings/0000023197-26-000037.md) | [36.1](/filings/0000023197-26-000069.md) | [(11.9) d](/filings/0000023197-26-000114.md) |
| Research and development | $m | [7.8](/filings/0000023197-25-000009.md) | [6.8](/filings/0000023197-25-000039.md) | [5.7](/filings/0000023197-25-000056.md) | [3.7 d](/filings/0000023197-25-000080.md) | [3.7](/filings/0000023197-25-000100.md) | [4.4](/filings/0000023197-26-000037.md) | [4.4](/filings/0000023197-26-000069.md) | [(0.8) d](/filings/0000023197-26-000114.md) | [3.8](/filings/0000023197-25-000100.md) | [4.4](/filings/0000023197-26-000037.md) | [5.2](/filings/0000023197-26-000069.md) | [(1.9) d](/filings/0000023197-26-000114.md) |
| Selling, general and administrative | $m | [32.7](/filings/0000023197-25-000009.md) | [30.3](/filings/0000023197-25-000039.md) | [28.7](/filings/0000023197-25-000056.md) | [31.5 d](/filings/0000023197-25-000080.md) | [51.6](/filings/0000023197-25-000100.md) | [33.8](/filings/0000023197-26-000037.md) | [30.2](/filings/0000023197-26-000069.md) | [(27.6) d](/filings/0000023197-26-000114.md) | [29.9](/filings/0000023197-25-000100.md) | [27.7](/filings/0000023197-26-000037.md) | [29.3](/filings/0000023197-26-000069.md) | [0.9 d](/filings/0000023197-26-000114.md) |
| Operating income | $m | [2.1](/filings/0000023197-25-000009.md) | [3.0](/filings/0000023197-25-000039.md) | [(3.5)](/filings/0000023197-25-000056.md) | [(81.5) d](/filings/0000023197-25-000080.md) | [(129)](/filings/0000023197-25-000100.md) | [(10.3)](/filings/0000023197-26-000037.md) | [(1.5)](/filings/0000023197-26-000069.md) | [111 d](/filings/0000023197-26-000114.md) | [(2.8)](/filings/0000023197-25-000100.md) | [(1.2)](/filings/0000023197-26-000037.md) | [(3.1)](/filings/0000023197-26-000069.md) | [(11.1) d](/filings/0000023197-26-000114.md) |
| Interest expense | $m | [4.9](/filings/0000023197-25-000009.md) | [5.3](/filings/0000023197-25-000039.md) | [5.1](/filings/0000023197-25-000056.md) | [6.8 d](/filings/0000023197-25-000080.md) | [9.5](/filings/0000023197-25-000100.md) | [11.0](/filings/0000023197-26-000037.md) | [12.9](/filings/0000023197-26-000069.md) | [12.2 d](/filings/0000023197-25-000080.md) | [11.6](/filings/0000023197-25-000100.md) | [11.2](/filings/0000023197-26-000037.md) | [11.5](/filings/0000023197-26-000069.md) | [(13.0) d](/filings/0000023197-26-000114.md) |
| Income tax | $m | [(1.3)](/filings/0000023197-25-000009.md) | [7.4](/filings/0000023197-25-000039.md) | [(5.4)](/filings/0000023197-25-000056.md) | [(0.9) d](/filings/0000023197-25-000080.md) | [2.1](/filings/0000023197-25-000100.md) | [(1.0)](/filings/0000023197-26-000037.md) | [(1.8)](/filings/0000023197-26-000069.md) | [0.4 d](/filings/0000023197-26-000114.md) | [0.4](/filings/0000023197-25-000100.md) | [0.0](/filings/0000023197-26-000037.md) | [1.3](/filings/0000023197-26-000069.md) | [(0.9) d](/filings/0000023197-26-000114.md) |
| Net income | $m | [(1.4)](/filings/0000023197-25-000009.md) | [(10.6)](/filings/0000023197-25-000039.md) | [2.8](/filings/0000023197-25-000056.md) | [(90.8) d](/filings/0000023197-25-000080.md) | [(148)](/filings/0000023197-25-000100.md) | [(48.7)](/filings/0000023197-26-000037.md) | [33.9](/filings/0000023197-26-000069.md) | [7.9 d](/filings/0000023197-26-000114.md) | [(15.9)](/filings/0000023197-25-000100.md) | [(13.6)](/filings/0000023197-26-000037.md) | [(3.5)](/filings/0000023197-26-000069.md) | [(3.2) d](/filings/0000023197-26-000114.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0000023197-25-000009.md) | [(1.07)](/filings/0000023197-25-000039.md) | [(0.04)](/filings/0000023197-25-000056.md) | not reported | [(5.29)](/filings/0000023197-25-000100.md) | [(0.76)](/filings/0000023197-26-000037.md) | [(0.49)](/filings/0000023197-26-000069.md) | not reported | [(0.67)](/filings/0000023197-25-000100.md) | [(0.68)](/filings/0000023197-26-000037.md) | [(0.47)](/filings/0000023197-26-000069.md) | not reported |
| Basic EPS | $ per share | [(0.11)](/filings/0000023197-25-000009.md) | [(1.07)](/filings/0000023197-25-000039.md) | [(0.04)](/filings/0000023197-25-000056.md) | not reported | [(5.29)](/filings/0000023197-25-000100.md) | [(0.76)](/filings/0000023197-26-000037.md) | [(0.49)](/filings/0000023197-26-000069.md) | not reported | [(0.67)](/filings/0000023197-25-000100.md) | [(0.68)](/filings/0000023197-26-000037.md) | [(0.47)](/filings/0000023197-26-000069.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.1](/filings/0000023197-23-000070.md) | [40.0](/filings/0000023197-24-000041.md) | [27.2](/filings/0000023197-24-000080.md) | [32.4](/filings/0000023197-25-000080.md) | [29.6](/filings/0000023197-25-000009.md) | [26.7](/filings/0000023197-25-000039.md) | [28.4](/filings/0000023197-25-000056.md) | [35.4](/filings/0000023197-26-000114.md) | [43.6](/filings/0000023197-25-000100.md) | [32.8](/filings/0000023197-26-000037.md) | [28.5](/filings/0000023197-26-000069.md) | [35.0](/filings/0000023197-26-000114.md) |
| Current assets | $m | [354](/filings/0000023197-23-000070.md) | [343](/filings/0000023197-24-000041.md) | [344](/filings/0000023197-24-000080.md) | [337](/filings/0000023197-25-000080.md) | [307](/filings/0000023197-25-000009.md) | [290](/filings/0000023197-25-000039.md) | [275](/filings/0000023197-25-000056.md) | [271](/filings/0000023197-26-000114.md) | [267](/filings/0000023197-25-000100.md) | [242](/filings/0000023197-26-000037.md) | [237](/filings/0000023197-26-000069.md) | [243](/filings/0000023197-26-000114.md) |
| Total assets | $m | [1,013](/filings/0000023197-25-000009.md) | [997](/filings/0000023197-25-000039.md) | [991](/filings/0000023197-25-000056.md) | [793](/filings/0000023197-25-000100.md) | [793](/filings/0000023197-25-000009.md) | [771](/filings/0000023197-26-000037.md) | [751](/filings/0000023197-26-000069.md) | [742](/filings/0000023197-26-000114.md) | [734](/filings/0000023197-25-000100.md) | [704](/filings/0000023197-26-000037.md) | [693](/filings/0000023197-26-000069.md) | [696](/filings/0000023197-26-000114.md) |
| Current liabilities | $m | [391](/filings/0000023197-23-000070.md) | [347](/filings/0000023197-24-000041.md) | [193](/filings/0000023197-24-000080.md) | [184](/filings/0000023197-25-000080.md) | [383](/filings/0000023197-25-000009.md) | [385](/filings/0000023197-25-000039.md) | [373](/filings/0000023197-25-000056.md) | [158](/filings/0000023197-26-000114.md) | [157](/filings/0000023197-25-000100.md) | [143](/filings/0000023197-26-000037.md) | [147](/filings/0000023197-26-000069.md) | [291](/filings/0000023197-26-000114.md) |
| Total liabilities | $m | [462](/filings/0000023197-23-000070.md) | [423](/filings/0000023197-24-000041.md) | [414](/filings/0000023197-24-000080.md) | [426](/filings/0000023197-25-000080.md) | [494](/filings/0000023197-25-000009.md) | [520](/filings/0000023197-25-000039.md) | [466](/filings/0000023197-25-000056.md) | [448](/filings/0000023197-26-000114.md) | [455](/filings/0000023197-25-000100.md) | [438](/filings/0000023197-26-000037.md) | [430](/filings/0000023197-26-000069.md) | [435](/filings/0000023197-26-000114.md) |
| Long-term debt | $m | [0.0](/filings/0000023197-23-000070.md) | [0.0](/filings/0000023197-24-000041.md) | [158](/filings/0000023197-24-000080.md) | [174](/filings/0000023197-25-000056.md) | [0.0](/filings/0000023197-25-000009.md) | [0.0](/filings/0000023197-25-000039.md) | [0.0](/filings/0000023197-25-000056.md) | [114](/filings/0000023197-26-000069.md) | [117](/filings/0000023197-25-000100.md) | [108](/filings/0000023197-26-000037.md) | [104](/filings/0000023197-26-000069.md) | not reported |
| Current portion of debt | $m | [184](/filings/0000023197-23-000070.md) | [168](/filings/0000023197-24-000041.md) | [3.7](/filings/0000023197-24-000080.md) | [4.1](/filings/0000023197-25-000080.md) | [182](/filings/0000023197-25-000009.md) | [186](/filings/0000023197-25-000039.md) | [149](/filings/0000023197-25-000056.md) | [4.1](/filings/0000023197-26-000069.md) | [4.1](/filings/0000023197-25-000100.md) | [4.1](/filings/0000023197-26-000037.md) | [4.1](/filings/0000023197-26-000069.md) | not reported |
| Shareholders' equity | $m | [437](/filings/0000023197-23-000070.md) | [407](/filings/0000023197-24-000041.md) | [406](/filings/0000023197-24-000080.md) | [306](/filings/0000023197-25-000080.md) | [150](/filings/0000023197-25-000009.md) | [129](/filings/0000023197-25-000039.md) | [115](/filings/0000023197-25-000056.md) | [104](/filings/0000023197-26-000114.md) | [85.6](/filings/0000023197-25-000100.md) | [65.6](/filings/0000023197-26-000037.md) | [52.5](/filings/0000023197-26-000069.md) | [38.9](/filings/0000023197-26-000114.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.5)](/filings/0000023197-25-000009.md) | [(26.7) d](/filings/0000023197-25-000039.md) | [(3.8) d](/filings/0000023197-25-000056.md) | [(9.5) d](/filings/0000023197-25-000080.md) | [(21.8)](/filings/0000023197-25-000100.md) | [(0.2) d](/filings/0000023197-26-000037.md) | [2.3 d](/filings/0000023197-26-000069.md) | [11.4 d](/filings/0000023197-26-000114.md) | [8.1](/filings/0000023197-25-000100.md) | [4.9 d](/filings/0000023197-26-000037.md) | [6.1 d](/filings/0000023197-26-000069.md) | [18.4 d](/filings/0000023197-26-000114.md) |
| Capital expenditure | $m | [3.2](/filings/0000023197-25-000009.md) | [4.3](/filings/0000023197-24-000041.md) | [2.7](/filings/0000023197-24-000080.md) | [4.2 d](/filings/0000023197-25-000080.md) | [2.4](/filings/0000023197-25-000100.md) | [1.7 d](/filings/0000023197-26-000037.md) | [2.5 d](/filings/0000023197-26-000069.md) | [1.7 d](/filings/0000023197-26-000114.md) | [3.3](/filings/0000023197-25-000100.md) | [4.4 d](/filings/0000023197-26-000037.md) | [5.4 d](/filings/0000023197-26-000069.md) | [2.1 d](/filings/0000023197-26-000114.md) |
| Dividends paid | $m | [0.1](/filings/0000023197-25-000009.md) | [0.2 d](/filings/0000023197-25-000039.md) | [0.0 d](/filings/0000023197-25-000056.md) | [0.0 d](/filings/0000023197-25-000080.md) | [0.0](/filings/0000023197-25-000100.md) | [0.1 d](/filings/0000023197-26-000037.md) | [0.0 d](/filings/0000023197-26-000069.md) | [0.0 d](/filings/0000023197-26-000114.md) | [0.0](/filings/0000023197-25-000100.md) | [0.0 d](/filings/0000023197-26-000037.md) | [0.0 d](/filings/0000023197-26-000069.md) | [0.0 d](/filings/0000023197-26-000114.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.8](/filings/0000023197-23-000070.md) | [28.0](/filings/0000023197-24-000041.md) | [28.1](/filings/0000023197-24-000080.md) | [28.7](/filings/0000023197-25-000009.md) | [28.7](/filings/0000023197-25-000039.md) | [28.9](/filings/0000023197-25-000056.md) | [29.4](/filings/0000023197-25-000100.md) | [29.3](/filings/0000023197-26-000037.md) | [29.4](/filings/0000023197-26-000069.md) | [29.6](/filings/0000023197-25-000100.md) | [29.8](/filings/0000023197-26-000037.md) | [30.0](/filings/0000023197-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,137,266 at 2026-10-08, from the cover of the [10-K filed 2026-10-14](/filings/0000023197-26-000114.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.